{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:37:28Z","timestamp":1793191048894,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SPMSD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3121-x","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T12:07:47Z","timestamp":1525349267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk and impact of herpes zoster among COPD patients: a population-based study, 2009\u20132014"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-4905","authenticated-orcid":false,"given":"Cintia","family":"Mu\u00f1oz-Quiles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"L\u00f3pez-Lacort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edez-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"issue":"16","key":"3121_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182(16):1731\u20136.","journal-title":"CMAJ"},{"key":"3121_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1086\/522123","volume":"197","author":"AM Arvin","year":"2008","unstructured":"Arvin AM. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis. 2008;197:S58\u201360.","journal-title":"J Infect Dis"},{"issue":"16","key":"3121_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371(16):1526\u201333.","journal-title":"N Engl J Med"},{"key":"3121_CR4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1186\/s12889-015-1514-y","volume":"15","author":"A Gater","year":"2015","unstructured":"Gater A, Uhart M, McCool R, Preaud E. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health. 2015;15:1514.","journal-title":"BMC Public Health"},{"issue":"10","key":"3121_CR5","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/320169","volume":"32","author":"K Schmader","year":"2001","unstructured":"Schmader K. Herpes zoster in older adults. Clin Infect Dis. 2001;32(10):1481\u20136.","journal-title":"Clin Infect Dis"},{"key":"3121_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/1471-2334-13-463","volume":"13","author":"N Morant-Talamante","year":"2013","unstructured":"Morant-Talamante N, Diez-Domingo J, Martinez-Ubeda S, Puig-Barbera J, Aleman-Sanchez S, Perez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian community (Spain). BMC Infect Dis. 2013;13:463.","journal-title":"BMC Infect Dis"},{"key":"3121_CR7","first-page":"g2911","volume":"348","author":"HJ Forbes","year":"2014","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM. Quantification of risk factors for herpes zoster: population based case-control study. BMJ (Clinical research ed). 2014;348:g2911.","journal-title":"BMJ (Clinical research ed)"},{"issue":"6","key":"3121_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.4161\/hv.28620","volume":"10","author":"MD Esteban-Vasallo","year":"2014","unstructured":"Esteban-Vasallo MD, Dominguez-Berjon MF, Gil-Prieto R, Astray-Mochales J, de Miguel AG. Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster A population-based study from primary care in Madrid (Spain). Hum Vaccin Immunother. 2014;10(6):1650\u201360.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"3121_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1212\/WNL.0000000000002808","volume":"87","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Mansfield K, Minassian C, Langan SM. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: a cohort study. Neurol. 2016;87(1):94\u2013102.","journal-title":"Neurol"},{"issue":"11","key":"3121_CR10","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","volume":"13","author":"C Mu\u00f1oz-Quiles","year":"2017","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, Ampudia-Blasco FJ, D\u00edez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009-2014. Hum Vaccin Immunother. 2017;13(11):2606\u201311.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"3121_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4\u201314.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"3121_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3121_CR13","first-page":"265","volume":"72","author":"P Kuhdari","year":"2016","unstructured":"Kuhdari P, Zorzoli E, D'Alo GL, Brosio F, Bonanni P, Valente S, Gabutti G, Franco E. The public health importance of vaccinations in the elderly: an evidence-based guide. Ig Sanita Pubbl. 2016;72(3):265\u201392.","journal-title":"Ig Sanita Pubbl"},{"issue":"1","key":"3121_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40520-015-0314-7","volume":"27","author":"S Maggi","year":"2015","unstructured":"Maggi S, Gabutti G, Franco E, Bonanni P, Conversano M, Ferro A, Lazzari M, Rossi A, Scotti S, Vitale F, et al. Preventing and managing herpes zoster: key actions to foster healthy aging. Aging Clin Exp Res. 2015;27(1):5\u201311.","journal-title":"Aging Clin Exp Res"},{"issue":"22","key":"3121_CR15","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"issue":"(RR-5)","key":"3121_CR16","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices Centers for D, Control and P. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm Rep: Morb Mortal Wkly Rep. Recomm Reps \/ CDC. 2008;57((RR-5)):1\u201330. quiz CE32\u201334","journal-title":"MMWR. Recomm Rep: Morb Mortal Wkly Rep. Recomm Reps \/ CDC"},{"issue":"2","key":"3121_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jama.2010.1983","volume":"305","author":"HF Tseng","year":"2011","unstructured":"Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160\u20136.","journal-title":"JAMA"},{"issue":"4","key":"3121_CR18","doi-asserted-by":"publisher","first-page":"e1001420","DOI":"10.1371\/journal.pmed.1001420","volume":"10","author":"SM Langan","year":"2013","unstructured":"Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med. 2013;10(4):e1001420.","journal-title":"PLoS Med"},{"key":"3121_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1099\/jmm.0.000386","volume":"65","author":"G Gabutti","year":"2016","unstructured":"Gabutti G, Valente N, Kuhdari P, Lupi S, Stefanati A. Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. J Med Microbiol. 2016;65:1363\u20139.","journal-title":"J Med Microbiol"},{"issue":"23","key":"3121_CR20","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1056\/NEJMra0804752","volume":"360","author":"MG Cosio","year":"2009","unstructured":"Cosio MG, Saetta M, Agusti A. MECHANISMS OF DISEASE Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(23):2445\u201354.","journal-title":"N Engl J Med"},{"issue":"9795","key":"3121_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","volume":"378","author":"GG Brusselle","year":"2011","unstructured":"Brusselle GG, Joos GF, Bracke KR. Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015\u201326.","journal-title":"Lancet"},{"issue":"5","key":"3121_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nm1583","volume":"13","author":"S-H Lee","year":"2007","unstructured":"Lee S-H, Goswami S, Grudo A, Song L-z, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007;13(5):567\u20139.","journal-title":"Nat Med"},{"key":"3121_CR23","doi-asserted-by":"crossref","unstructured":"Patel ARC, Karmali S, Donaldson GC, Goldring JJP, Wedzicha JA, Hurst JR. Prevalence of herpes zoster in COPD and relationships with inhaled corticosteroids, exacerbation frequency and FEV1. Am J Respir Crit Care Med. 2010;181: Abstract number A5926.","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A5926"},{"issue":"5","key":"3121_CR24","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1503\/cmaj.101137","volume":"183","author":"Y-W Yang","year":"2011","unstructured":"Yang Y-W, Chen Y-H, Wang K-H, Wang C-Y, Lin H-W. Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study. Can Med Assoc J. 2011;183(5):E275\u201380.","journal-title":"Can Med Assoc J"},{"key":"3121_CR25","doi-asserted-by":"publisher","unstructured":"Ernst P, Dell'Aniello S, Mikaeloff Y, Suissa S. Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study. BMC Pulm Med. 2011;11:59. https:\/\/doi.org\/10.1186\/1471-2466-11-59 .","DOI":"10.1186\/1471-2466-11-59"},{"key":"3121_CR26","volume-title":"Cifras oficiales de poblaci\u00f3n resultantes de la revisi\u00f3n del Padr\u00f3n municipal a 1 de Enero de 2014","author":"Instituto Nacional de Estad\u00edstica","year":"2014","unstructured":"Instituto Nacional de Estad\u00edstica: Cifras oficiales de poblaci\u00f3n resultantes de la revisi\u00f3n del Padr\u00f3n municipal a 1 de Enero de 2014. 2014; http:\/\/www.ine.es\/dynt3\/inebase\/es\/index.html?padre=517&dh=1 ."},{"key":"3121_CR27","unstructured":"Indra Sistemas SA. Proyecto Abucasis Conselleria Sanitat Valencia. http:\/\/www.indracompany.com\/sectores\/sanidad\/proyectos\/179\/proyecto-abucasis-conselleria-de-sanitat-valencia . Accessed 1 Jan 2016."},{"issue":"4","key":"3121_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","volume":"42","author":"AP Guignard","year":"2014","unstructured":"Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection. 2014;42(4):729\u201335.","journal-title":"Infection"},{"issue":"3","key":"3121_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/INF.0000000000000993","volume":"35","author":"C Munoz-Quiles","year":"2016","unstructured":"Munoz-Quiles C, Lopez-Lacort M, Ubeda-Sansano I, Aleman-Sanchez S, Perez-Vilar S, Puig-Barbera J, Diez-Domingo J. Population-based analysis of bronchiolitis epidemiology in Valencia, Spain. Pediatr Infect Dis J. 2016;35(3):275\u201380.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"3121_CR30","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.mayocp.2012.05.021","volume":"87","author":"RM Joesoef","year":"2012","unstructured":"Joesoef RM, Harpaz R, Leung J, Bialek SR. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012;87(10):961\u20137.","journal-title":"Mayo Clin Proc"},{"key":"3121_CR31","first-page":"14","volume":"4","author":"L Chen","year":"2016","unstructured":"Chen L, Chen G, Zhang MQ, Xiong XZ, Liu HJ, Xin JB, Zhang JC, Wu JH, Meng ZJ, Sun SW. Imbalance between subsets of CD8(+) peripheral blood T cells in patients with chronic obstructive pulmonary disease. PeerJ. 2016;4:14.","journal-title":"PeerJ"},{"issue":"Suppl 2","key":"3121_CR32","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1513\/AnnalsATS.201503-126AW","volume":"12","author":"TA Bhat","year":"2015","unstructured":"Bhat TA, Panzica L, Kalathil SG, Thanavala Y. Immune dysfunction in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2015;12(Suppl 2):S169\u201375.","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"3121_CR33","first-page":"1091","volume":"72","author":"L Torcel-Pagnon","year":"2017","unstructured":"Torcel-Pagnon L, Bricout H, Bertrand I, Perinetti E, Franco E, Gabutti G, Volpi A. Impact of underlying conditions on zoster-related pain and on quality of life following zoster. J Gerontol A Biol Sci Med Sci. 2017;72(8):1091\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3121_CR34","doi-asserted-by":"crossref","unstructured":"Lopez-Belmonte JL, Cisterna R, Gil de Miguel A, Guillmet C, Bianic F, Uhart M. The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50years and older. J Med Econ. 19(6):576\u201386.","DOI":"10.3111\/13696998.2016.1146726"},{"issue":"7","key":"3121_CR35","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1080\/21645515.2015.1049787","volume":"11","author":"S P\u00e9rez-Vilar","year":"2015","unstructured":"P\u00e9rez-Vilar S, D\u00edez-Domingo J, Puig-Barber\u00e1 J, Gil-Prieto R, Romio S. Intussusception following rotavirus vaccination in the Valencia region, Spain. Hum Vaccin Immunother. 2015;11(7):1848\u201352.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3121-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T18:44:14Z","timestamp":1661107454000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3121-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3121"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3121-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Direcci\u00f3n General de Salud P\u00fablica \/ Centro Superior de Investigaci\u00f3n en Salud P\u00fablica. In order to protect personal data, the original datasets were dissociated by the database\u2019s managers. Moreover, consent was waived by the IRB (Ethics Committee of Direcci\u00f3n General de Salud P\u00fablica \/ Centro Superior de Investigaci\u00f3n en Salud P\u00fablica).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JDD and his institution received research grants from SPMSD related to HZ vaccine. He also acted as advisor for these vaccines to GSK and SPMSD. CMQ has attended to several congresses whose registration, travel and accommodation costs have been covered by SPMSD. MLL has reported that no potential conflicts of interest exist with any companies\/organizations whose products or services may be discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"203"}}